Meridian Oncology Associates Pllc
Non-pharmacy Dispensing Site
1704 23rd Ave, 2nd Flr, Meridian
Mississippi, 39301-3103
601-482-1555 601-696-4611
Meridian Oncology Associates Pllc is an authorized DME supplier for medicare equipments and products.
Meridian Oncology Associates Pllc is a Non-pharmacy Dispensing Site in Meridian, Mississippi. It is located at 1704 23rd Ave, 2nd Flr, Meridian and it's customer support contact number is 601-482-1555. The authorized person of Meridian Oncology Associates Pllc is Wendy Turner who is Clinic Manager of the pharmacy and his contact number is 601-482-1555. Active license number of Meridian Oncology Associates Pllc is 20329 for Non-pharmacy Dispensing Site in Mississippi. Meridian Oncology Associates Pllc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Meridian Oncology Associates Pllc is a site other than a pharmacy that dispenses medicinal preparations under the supervision of a physician to patients for self-administration. (e.g. physician offices, ER, Urgent Care Centers, Rural Health Facilities, etc.)
Pharmacy Details:
Meridian Oncology Associates Pllc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | Meridian Oncology Associates Pllc |
| Type: | Non-pharmacy Dispensing Site |
| Location: | 1704 23rd Ave, 2nd Flr, Meridian, Mississippi, 39301-3103 |
| Phone: | 601-482-1555 |
| Fax: | 601-696-4611 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Wendy Turner |
| Position: | Clinic Manager |
| Contact Number: | 601-482-1555 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1164433678 |
| NPI Enumeration Date: | 10 Aug, 2006 |
| NPI Last Update On: | 11 Sep, 2017 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Meridian Oncology Associates Pllc are as mentioned below.
| Specialization | License Number | State | Status | |
| Non-pharmacy Dispensing Site | 20329 | Mississippi | Primary | |
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
| Identifier | Type | State | Issuer |
| 2586610 | Other | | Other Id Number-commercial Number |
| 2586610 | Other | | Other Id Number |
| 5939260001 | Other | Mississippi | Ptan |
| CF9149 | Other | Mississippi | Railroad Group # |
Medicare Enrollment:
Meridian Oncology Associates Pllc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 7012084940 | O20080918000518 | Meridian Oncology Associates Pllc | PART B SUPPLIER - CLINIC/GROUP PRACTICE |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 1704 23rd Ave, 2nd Flr Meridian, Mississippi |
| Zip: | 39301-3103 |
| Phone Number: | -- |
Patients can reach Meridian Oncology Associates Pllc at
1704 23rd Ave, 2nd Flr, Meridian, Mississippi or can
call on customer care at 601-482-1555.
Comments/ Reviews:
Read all the reviews posted for Meridian Oncology Associates Pllc below. You may also share your own experience with Meridian Oncology Associates Pllc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.